Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

AST SpaceMobile Shares Plunge Following Severe Analyst Downgrade

Felix Baarz by Felix Baarz
January 7, 2026
in Analysis, Space, Tech & Software, Telecommunications
0
ASTeMobile Stock
0
SHARES
14
VIEWS
Share on FacebookShare on Twitter

Shares of satellite communications firm AST SpaceMobile are experiencing a sharp sell-off today. The catalyst is a severe rating cut from Canadian investment bank Scotiabank, which has issued a new price target of just $45.60. This represents a potential downside of over 50% from the previous day’s closing price, with the bank’s analyst calling the current valuation “irrational.”

A Market Reassessment Underway

The market’s reaction was swift. After closing at $97.49 on Tuesday, the stock opened significantly lower today, shedding as much as 8% in early trading. This move abruptly halts a rally that had seen the shares gain more than 30% in the initial trading sessions of 2026.

Scotiabank analyst Andres Coello drove the negative sentiment by downgrading the stock from “Sector Perform” to “Sector Underperform.” The core of his critique centers on significant operational delays. The bank now projects that AST SpaceMobile will not generate its first substantial free cash flows until 2028 or 2029. The report also highlights a slow pace of customer acquisition in crucial markets, including the United States and Japan, all while the company faces substantial capital expenditures.

Underlying Financial and Insider Concerns

This analyst skepticism aligns with recent fundamental weaknesses. The company’s quarterly results from November 2025 fell well short of expectations, underscoring the challenges:
* Earnings Per Share (EPS): -$0.45 (Consensus Expectation: approximately -$0.21)
* Revenue: $14.74 million (Consensus Expectation: approximately $22 million)

Should investors sell immediately? Or is it worth buying ASTeMobile?

This financial performance has been accompanied by notable insider selling activity. Major shareholder Tower Corp (American Tower) slashed its position by roughly 91.5% in December 2025, offloading 2.29 million shares. The company’s Chief Technology Officer, Huiwen Yao, also sold shares during the same month.

The Daunting Competitive Landscape

A further critical point raised by analysts is the immense competitive gap. Rival SpaceX’s Starlink network holds a commanding lead. While AST SpaceMobile has launched seven satellites since 2017—the most recent being “BlueBird 6” in December 2025—Starlink deployed over 3,160 satellites in 2025 alone. Industry estimates suggest AST SpaceMobile requires approximately 50 satellites in orbit to offer a continuous service, a goal it aims to reach by the end of 2026.

Given these execution risks and the capital-intensive path to profitability, the stock’s current valuation is coming under intense scrutiny. Many observers now consider a price-to-book ratio of 29.1 to be excessive, prompting a rigorous market reassessment of the company’s prospects.

Ad

ASTeMobile Stock: Buy or Sell?! New ASTeMobile Analysis from February 7 delivers the answer:

The latest ASTeMobile figures speak for themselves: Urgent action needed for ASTeMobile investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

ASTeMobile: Buy or sell? Read more here...

Tags: ASTeMobile
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Diginex Stock
Blockchain

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock
Analysis

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Next Post
Apollo Global Management Stock

Apollo's Strategic Pivot: Financing the AI Infrastructure Boom

BWX Technologies Stock

Regulatory Hurdle Emerges for BWX Technologies' Tennessee Expansion

Medical Properties Stock

Medical Properties Trust: A High-Stakes Options Play

Recommended

Jakks Pacific Reports Disappointing Q4 2023 Earnings

2 years ago
Ecommerce Stock Exchange

Notable Options Market Activity for Shopify

2 years ago
Fannie Mae Stock

Fannie Mae’s Public Offering Plans Derailed by Prominent Investor

3 months ago
Ocugen Stock

Ocugen Shares Face Critical Test Amid Steep Decline

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Trending

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

by Rodolfo Hanigan
February 7, 2026
0

Investors in Viking Therapeutics are currently focused on a specific calendar event rather than breaking news. The...

Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment
  • Diginex Enters Critical Implementation Phase Following Strategic Moves
  • Deluxe Stock Gains Momentum on Successful Fintech Transition

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com